139 related articles for article (PubMed ID: 34315397)
21. Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis.
Xu Y; Zhang M; Zhang J; Ng DM; Chen X; Si Y; Shi Y; Li X; Mao D; Yang L
Taiwan J Obstet Gynecol; 2021 May; 60(3):433-441. PubMed ID: 33966724
[TBL] [Abstract][Full Text] [Related]
22. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.
Li R; Wang Q; Zhang B; Yuan Y; Xie W; Huang X; Zhou C; Zhang S; Niu S; Chang H; Chen D; Miao H; Zeng ZF; Xiao W; Gao Y
BMC Cancer; 2021 Dec; 21(1):1333. PubMed ID: 34906114
[TBL] [Abstract][Full Text] [Related]
24. A Systematic Review and Bayesian Network Meta-Analysis: Short-Term and Long-Term Outcomes of Three Surgery Procedures Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Wang L; Zhang Z; Gong L; Zhan Y; Li M; Li S; Xiao Y
J Laparoendosc Adv Surg Tech A; 2019 May; 29(5):663-670. PubMed ID: 30648922
[No Abstract] [Full Text] [Related]
25. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
[TBL] [Abstract][Full Text] [Related]
26. Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data.
Li JY; Huang XZ; Gao P; Song YX; Chen XW; Lv XE; Fu Y; Xiao Q; Ye SY; Wang ZN
BMC Cancer; 2021 Nov; 21(1):1214. PubMed ID: 34773999
[TBL] [Abstract][Full Text] [Related]
27. Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer.
Banwell VC; Phillips HA; Duff MJ; Speake D; McLean C; Williams LJ; He Y; Paterson HM
Acta Oncol; 2019 Sep; 58(9):1267-1272. PubMed ID: 31237192
[No Abstract] [Full Text] [Related]
28. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
29. Predictive role of preoperative sarcopenia for long-term survival in rectal cancer patients: A meta-analysis.
Su Q; Shen J
PLoS One; 2024; 19(5):e0303494. PubMed ID: 38771764
[TBL] [Abstract][Full Text] [Related]
30. KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis.
Peng J; Lv J; Peng J
Int J Colorectal Dis; 2021 Aug; 36(8):1781-1790. PubMed ID: 33760952
[TBL] [Abstract][Full Text] [Related]
31. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
An X; Lin X; Wang FH; Goodman K; Cai PQ; Kong LH; Fang YJ; Gao YH; Lin JZ; Wan DS; Pan ZZ; Ding PR
Eur J Cancer; 2013 Mar; 49(4):843-51. PubMed ID: 23063351
[TBL] [Abstract][Full Text] [Related]
32. A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.
Petrelli F; Coinu A; Lonati V; Barni S
Int J Colorectal Dis; 2015 Apr; 30(4):447-57. PubMed ID: 25433820
[TBL] [Abstract][Full Text] [Related]
33. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
34. Preoperative chemoradiotherapy with oxaliplatin and tegafur-uracil in locally advanced rectal cancer: pathologic complete response rate and preliminary results of overall and disease-free survival in a single institute in Taiwan.
Chao JY; Wang HM; Chiang FF; Lin JC; Chang CF; Lin JF; Yeh HL
J Chin Med Assoc; 2014 Mar; 77(3):128-32. PubMed ID: 24398439
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
[TBL] [Abstract][Full Text] [Related]
36. Preoperative short-course radiotherapy (5 × 5 Gy) with delayed surgery versus preoperative long-course radiotherapy for locally resectable rectal cancer: a meta-analysis.
Qiaoli W; Yongping H; Wei X; Guoqiang X; Yunhe J; Qiuyan L; Cheng L; Mengling G; Jiayi L; Wei X; Yi Y
Int J Colorectal Dis; 2019 Dec; 34(12):2171-2183. PubMed ID: 31745621
[TBL] [Abstract][Full Text] [Related]
37. Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment.
Li JY; Huang XZ; Gao P; Chen XW; Song YX; Lv XE; Fu Y; Xiao Q; Wang ZN
Biomed Res Int; 2021; 2021():8852699. PubMed ID: 34337057
[TBL] [Abstract][Full Text] [Related]
38. Wait and see approach for rectal cancer with a clinically complete response after neoadjuvant concurrent chemoradiotherapy.
Kim HJ; Song JH; Ahn HS; Choi BH; Jeong H; Choi HS; Lee YH; Kang KM; Jeong BK
Int J Colorectal Dis; 2017 May; 32(5):723-727. PubMed ID: 27885479
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant treatments for resectable rectal cancer: A network meta-analysis.
Zhong W; Xue X; Dai L; Li R; Nie K; Zhou S
Exp Ther Med; 2020 Apr; 19(4):2604-2614. PubMed ID: 32256740
[TBL] [Abstract][Full Text] [Related]
40. Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis.
Ma Z; Tan L; Liu ZL; Xiao JW
Front Surg; 2022; 9():911538. PubMed ID: 36090336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
